)
Ipca Laboratories (IPCALAB) investor relations material
Ipca Laboratories Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Domestic business grew 12% in Q3 FY26, outpacing the Indian Pharmaceutical Market's 8.9% growth year-over-year.
Export formulation business grew 17% in Q3 and 6% for the nine-month period; API business was flat in Q3 but up 14% for nine months.
Standalone net total income for Q3 FY26 rose 11% year-over-year to Rs. 1,863.00 crores; consolidated net total income increased 7% to Rs. 2,412.69 crores.
Standalone net profit for Q3 FY26 was Rs. 303.45 crores, up 13%; consolidated net profit was Rs. 326.27 crores, up 31%.
Consolidated Q3 revenue was INR 2,245 crore, up 6.5% year-over-year; nine-month consolidated revenue grew 8.44% to INR 7,258 crore.
Financial highlights
Standalone EBITDA margin improved to 26.09% in Q3 FY26 from 24.25% in Q3 FY25; consolidated EBITDA margin for Q3 FY26 was 22.15%, up from 19.87%.
Standalone EPS for Q3 FY26 was Rs. 11.96 (up 13%); consolidated EPS was Rs. 12.86 (up 31%).
For nine months FY26, standalone EBITDA margin was 25.15% (vs. 23.14%); consolidated EBITDA margin was 20.79% (vs. 19.18%).
Standalone net profit for nine months FY26 was Rs. 870.23 crores (up 22%); consolidated net profit was Rs. 842.05 crores (up 26%).
Material cost to sales ratio improved by 3.36 percentage points for nine months, driven by product mix and higher-margin business growth.
Outlook and guidance
Expect overall company growth of 10%-11% annually, with promotional branded and generic businesses each targeting 10%-12% growth.
EBITDA margin (ex-Unichem) expected to improve by 1.5% per year if top-line growth sustains at 10%-12%.
Unichem's top-line expected to grow 8%-10% annually, with EBITDA margin targeted at 15% in 2-3 years, improving to 20% as filings and registrations mature.
Management highlighted continued growth in both domestic and export markets, with strong performance in branded and generics segments.
Next Ipca Laboratories earnings date
Next Ipca Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)